Henderson, Nevada – October 27, 2021 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today confirmed it has submitted its response to the Food & Drug Administration’s (FDA) most recent questions and comments on the company’s Pre-market Approval (PMA) application. At this time there are no outstanding FDA information requests to UHP, however the FDA reserves […]
News
United Health Products Provides Business Update
Henderson, Nevada – October 7, 2021 – United Health Products, Inc. (OTCPK: UEEC), (UHP), developer, manufacturer and marketer of HemoStyp™, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent, today provided an update on its regulatory approval application process and other business activities. As part of its substantive review process to evaluate UHP’s PMA (Pre-market […]
United Health Products Provides Corporate Update and Announces Equity Financing
Initiation of laparoscopic study to expand potential Class III indications for HemoStyp® gauze Latest animal study demonstrates proof of concept and comparative performance of HemoStyp Gel format Discussions underway for clinical study to evaluate HemoStyp adhesive bandage benefits in hemodialysis applications $4,000,000 common stock purchase commitment to fund ongoing regulatory and product development priorities Henderson, […]
United Health Products’ HemoStyp® Gauze Advances to FDA Substantive Review
Henderson, Nevada – May 5, 2021 – United Health Products, Inc. (OTCPK: UEEC), (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated Cellulose hemostatic agent, received notification this week from the Food & Drug Administration (FDA) that, following the resubmission of its application for Pre-market Approval for HemoStyp gauze […]
United Health Products Obtains International Patent Protection Measures for HemoStyp® Hydrocolloid
Henderson, Nevada – February 17, 2021 – United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), developer of HemoStyp, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent, today announced the publication under the Patent Cooperation Treaty of its international patent application relating to any hydrocolloid format of HemoStyp. The Patent Cooperation Treaty (“PCT”) […]
United Health Products Bolsters Management Team and Issues Chairman’s Letter to Shareholders
Henderson, Nevada – December 15, 2020 – United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent, today announced the appointment of John Phillips to the newly created position of Vice President, Marketing & Commercial Strategy, effective December 15, 2020. John […]